Detectability of hypervascularity in early dynamic PET depends on tracer kinetics: 18 F-FDG versus 68 Ga-DOTATOC in hepatic NET metastasis
- PMID: 23663248
- DOI: 10.1111/liv.12192
Detectability of hypervascularity in early dynamic PET depends on tracer kinetics: 18 F-FDG versus 68 Ga-DOTATOC in hepatic NET metastasis
Similar articles
-
Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy.Eur J Nucl Med Mol Imaging. 2006 Oct;33(10):1115-22. doi: 10.1007/s00259-006-0110-x. Epub 2006 Jun 9. Eur J Nucl Med Mol Imaging. 2006. PMID: 16763820 Clinical Trial.
-
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: an endearing tool for preoperative risk assessment.Nucl Med Commun. 2020 Sep;41(9):896-905. doi: 10.1097/MNM.0000000000001236. Nucl Med Commun. 2020. PMID: 32796478
-
Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.Invest Radiol. 2014 Jan;49(1):7-14. doi: 10.1097/RLI.0b013e3182a4eb4a. Invest Radiol. 2014. PMID: 24002080
-
(68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives.Semin Nucl Med. 2011 Jul;41(4):314-21. doi: 10.1053/j.semnuclmed.2011.02.001. Semin Nucl Med. 2011. PMID: 21624565 Review.
-
Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.Hell J Nucl Med. 2013 May-Aug;16(2):97-102. doi: 10.1967/s002449910084. Epub 2013 May 20. Hell J Nucl Med. 2013. PMID: 23687644 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical